Skip to main content
. 2023 Jun 12;85(7):3323–3333. doi: 10.1097/MS9.0000000000000949

Table 3.

Laboratory findings of inpatients with COVID-19 with any central nervous system (CNS) symptoms

Median (range)
Total (N=1248) ICU-Admitted (N=387) Not ICU-Admitted (N=861)
Characteristic [N of Available/Checked data in total] Without CNS symptoms (N=727) With CNS symptoms (N=521) Wilcoxon test Z score P a Without CNS symptoms (N=199) With CNS symptoms (N=188) Wilcoxon test Z score P a Without CNS symptoms (N=528) With CNS symptoms (N=333) Wilcoxon test Z score P a
Count, ×109/l
 White blood cell [1220] 6.6 (1.3–69.7) 6.5 (0.9–29.2) −0.03 0.489 7.3 (1.8–31.3) 7.6 (1–29.2) 1.14 0.128 6.4 (1.3–69.7) 6.2 (0.9–23.3) −1.63 0.051
 Neutrophil [1190] 4.8 (0.6–83.8) 5 (0.3–75.4) −0.14 0.443 5.8 (0.6–28.5) 6.02 (0.3–26.7) 0.88 0.189 4.6 (0.7–83.8) 4.2 (0.3–75.4) −1.85 0.032
 Lymphocyte [1189] 0.9 (0–63.4) 0.9 (0.1–199) −0.96 0.167 0.7 (0.1–4.4) 0.8 (0.1–199) 0.62 0.267 1 (0–63.4) 1 (0.1–17.8) −0.88 0.190
 Platelet [1215] 210 (0.6–755) 191 (6.4–737) −3.21 0.0007 186.5 (46–755) 196.5 (25–685) 0.25 0.400 217 (0.6–660) 190 (6.4–737) −3.90 <0.0001
ESR, mm/h [93] 61 (2–6455) 73 (4–120) 1.40 0.081 74.5 (2–111) 85 (4–120) −1.28 0.099 56.5 (6–120) 51 (7–112) 0.28 0.390
CRP, mg/l [797] 82.6 (0.5–2200) 78.1 (0.07–400) −1.20 0.115 142.5 (1.2–400) 130.3 (2.4–400) −0.47 0.318 62 (0.5–2200) 45.7 (0.07–400) −2.51 0.006
D-dimer, mg/l [659] 1.31 (0.13–5000) 1.32 (0.19–5000) −0.85 0.197 1.40 (0.23–5000) 1.6 (0.19–5000) 0.19 0.426 1.3 (0.13–5000) 1.10 (0.19–5000) −1.50 0.067
Fibrinogen, mg/dl [118] 470 (2–6455) 524 (157–813) 1.22 0.112 480 (2–4980) 530 (157–813) −0.71 0.238 465 (216–6455) 502 (280–779) 0.67 0.250
Ferritin, ng/ml [564] 354.5 (2–7500) 397.3 (0.31–7470) 1.67 0.048 487 (2–4980) 490.6 (33–7470) 0.82 0.206 296 (2–7500) 309.2 (0.31–5529) 0.41 0.341
LDH, U/L [465] 303.5 (1.13–4521) 285 (3.7–4706) 0.53 0.298 343 (7.6–4521) 426 (106–4706) 1.76 0.039 278.5 (1.13–1644) 254 (3.7–960) −1.73 0.042
CK, U/L [292] 97 (2–60 000) 166 (11–60 000) 3.19 0.0007 156.5 (14–60 000) 285 (19–7977) −1.72 0.043 71 (2–1213) 100 (11–60 000) 1.68 0.047
Aminotransferase, U/L
 Alanine (ALT) [1075] 23 (1–2090) 25 (3–397) 0.70 0.240 24 (3–2090) 26 (4–397) 1.66 0.051 23 (1–1276) 24 (3–264) −0.55 0.293
 Aspartate (AST) [1076] 32 (8–10 750) 35 (3–2640) 1.39 0.083 37.5 (11–10 750) 42 (8–2640) 1.61 0.054 31 (8–1193) 31 (3–292) −0.21 0.417
BUN, mg/dl [1204] 18 (0.59–155) 23 (0.9–171) 5.76 <0.0001 23 (1–137) 26 (0.9–141) 2.35 0.009 16 (0.59–155) 21 (3–171) 4.75 <0.0001
Creatinine, mg/dl [1211] 0.94 (0.28–52) 1.07 (0.2–35) 3.75 <0.0001 1.01 (0.32–15.9) 1.22 (0.2–18) 2.11 0.017 0.92 (0.28–52) 1 (0.34–35) 2.51 0.006
PT, s [635] 10.9 (8.9–96.5) 11 (1.43–79) 1.52 0.064 10.9 (9.3–44.8) 11.1 (9.3–79) −0.78 0.217 10.8 (8.9–96.5) 10.9 (1.43–53.1) 1.10 0.135
PTT, s [384] 32.3 (0.9–139) 32.8 (10.3–150) 1.07 0.142 33.3 (22.8–139) 35.6 (20.7–150) −1.27 0.103 31.3 (0.9–139) 31.3 (10.3–112.6) 0.21 0.415
INR [637] 1 (0.37–38.4) 1 (0.46–8) 0.92 0.178 1 (0.9–4.3) 1.1 (0.46–8) −1.22 0.112 1 (0.37–38.4) 1 (0.9–5.4) −0.02 0.493
a

P values indicate differences between inpatients with COVID-19 without versus with CNS symptoms, and P less than 0.05 was considered statistically significant using the Wilcoxon Two-Sample Test.

BUN, blood urea nitrogen; CK, creatine kinase; CRP, C-reactive protein; ESR, erythrocyte sedimentation rate; INR, International normalized ratio; LDH, lactate dehydrogenase; PT, prothrombin time; PTT, partial thromboplastin time.

Bold values signify statistical significance.